Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records

Juan M. Banda*, Alison Callahan, Rainer Winnenburg, Howard R. Strasberg, Aurel Cami, Ben Y. Reis, Santiago Vilar, George Hripcsak, Michel Dumontier, Nigam Haresh Shah

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Several studies have demonstrated the ability to detect adverse events potentially related to multiple drug exposure via data mining. However, the number of putative associations produced by such computational approaches is typically large, making experimental validation difficult. We theorized that those potential associations for which there is evidence from multiple complementary sources are more likely to be true, and explored this idea using a published database of drug-drug-adverse event associations derived from electronic health records (EHRs).We prioritized drug-drug-event associations derived from EHRs using four sources of information: (1) public databases, (2) sources of spontaneous reports, (3) literature, and (4) non-EHR drug-drug interaction (DDI) prediction methods. After pre-filtering the associations by removing those found in public databases, we devised a ranking for associations based on the support from the remaining sources, and evaluated the results of this rank-based prioritization.We collected information for 5983 putative EHR-derived drug-drug-event associations involving 345 drugs and ten adverse events from four data sources and four prediction methods. Only seven drug-drug-event associations (
Original languageEnglish
Pages (from-to)45-57
JournalDrug Safety
Issue number1
Publication statusPublished - Jan 2016
Externally publishedYes


Dive into the research topics of 'Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records'. Together they form a unique fingerprint.

Cite this